Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →Yes. You can get prescription weight loss medication online in most U.S. states through a licensed telehealth provider. After a video or asynchronous visit, a clinician reviews your BMI and health history and, if you qualify, prescribes an FDA-approved GLP-1 such as semaglutide or tirzepatide, or a legally compounded version.
Can you really get weight loss medication online?
Yes. Online weight loss medication can be prescribed after a licensed clinician reviews your health history, BMI, current medicines, and safety risks. In many states, this can happen by video visit or by an asynchronous online visit, but state rules and clinician judgment decide what is allowed.
Telehealth is still medical care. A safe online visit should check for pregnancy, gallbladder disease, pancreatitis history, kidney disease, diabetes medicines, eating disorders, and thyroid cancer risk before prescribing a GLP-1 or GIP/GLP-1 medication [1][2][7].
What telehealth can and cannot prescribe
Telehealth clinicians can prescribe FDA-approved weight loss medicines when they are licensed in your state and the medicine is appropriate for you. Wegovy (semaglutide, a GLP-1 receptor agonist; also available as a compounded formulation through licensed 503A pharmacies when legally allowed) is FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition [1].
Zepbound (tirzepatide, a GIP/GLP-1 dual agonist; also available as a compounded formulation through licensed 503A pharmacies when legally allowed) is FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition [2]. Saxenda (liraglutide, a GLP-1 receptor agonist) is also FDA-approved for chronic weight management [3]. These medicines may support weight loss, but they can also cause nausea, vomiting, diarrhea, constipation, gallbladder problems, pancreatitis, kidney injury from dehydration, and other side effects [1][2][3]. Individual results vary.
Which states allow online GLP-1 prescriptions
Online prescribing availability varies by state. In general, the prescriber must be licensed where you are located at the time of care, and the pharmacy must follow state and federal rules [10]. A telehealth service should show where it operates and should not promise access in every state.
Which weight loss medications are available online?
Several prescription options may be available online after a medical review. GLP-1 receptor agonist medicines and related medicines work on appetite and fullness signals, but they differ in FDA status, route, cost, supply, and safety warnings. One key cutoff is BMI ≥30 or BMI ≥27 with a weight-related condition for many chronic weight-management labels [1][2][3].
Brand-name GLP-1s: Wegovy, Zepbound, Saxenda
Wegovy (semaglutide) is a once-weekly GLP-1 receptor agonist injection FDA-approved for chronic weight management and for reducing major adverse cardiovascular events in certain adults with cardiovascular disease and obesity or overweight [1]. In the STEP 1 trial, adults without diabetes who received semaglutide 2.4 mg once weekly plus lifestyle intervention lost more weight than those who received placebo plus lifestyle intervention; nausea, diarrhea, vomiting, and constipation were common [11].
Zepbound (tirzepatide) is a once-weekly GIP/GLP-1 dual agonist injection FDA-approved for chronic weight management [2]. In SURMOUNT-1, tirzepatide once weekly produced greater average weight reduction than placebo in adults with obesity or overweight without diabetes; gastrointestinal side effects were the most common adverse events, and individual results varied [12].
Saxenda (liraglutide) is a once-daily GLP-1 receptor agonist injection FDA-approved for chronic weight management [3]. In a 2015 trial, liraglutide 3.0 mg daily plus lifestyle counseling led to greater average weight loss than placebo, but nausea, vomiting, diarrhea, and gallbladder-related events occurred more often with liraglutide [13].
Off-label options: Ozempic, Mounjaro
Ozempic (semaglutide) is FDA-approved for type 2 diabetes and cardiovascular risk reduction in certain adults with type 2 diabetes, not for chronic weight management [4]. Mounjaro (tirzepatide) is FDA-approved to improve blood sugar control in adults with type 2 diabetes, not for chronic weight management [5]. A clinician may consider off-label prescribing, but this should be framed as medical judgment, not a shortcut, and the same safety warnings and side effects still matter [4][5].
Compounded semaglutide and tirzepatide from 503A pharmacies
Compounded semaglutide via 503A pharmacy and compounded tirzepatide via 503A pharmacy are not FDA-approved products. A 503A pharmacy is a state-licensed pharmacy that prepares a medication for an individual patient based on a valid prescription, and FDA rules limit when copies of commercially available drugs may be compounded [9].
The FDA has warned that compounded drug products do not go through FDA premarket review for safety, effectiveness, or quality [9]. This does not mean every compounded product is unsafe, but it does mean the prescriber and pharmacy should explain sourcing, sterility testing, dosing units, storage, and adverse-event reporting.
Oral options: oral semaglutide, orforglipron
Rybelsus (oral semaglutide) is FDA-approved for type 2 diabetes, not chronic weight management [6]. Higher-dose oral semaglutide has been studied for weight loss in the OASIS 1 trial, where oral semaglutide 50 mg daily produced greater average weight loss than placebo but also caused more gastrointestinal adverse events; individual results vary [14].
Orforglipron (INN; Foundayo has been discussed as a brand name in development) is an oral non-peptide GLP-1 receptor agonist under study for weight management and is not FDA-approved for weight loss as of this article. In a phase 2 trial, once-daily orforglipron produced greater average weight reduction than placebo, with gastrointestinal side effects reported more often in treatment groups [15].
Who qualifies for online weight loss medication?
Eligibility depends on your BMI, health history, medicines, and safety risks. Semaglutide and tirzepatide labels use weight-status criteria such as obesity or overweight with at least one weight-related condition, and many programs use BMI ≥30 or ≥27 with a comorbidity as a starting point [1][2][7].
BMI and health-condition criteria
For many anti-obesity medicines, clinicians consider adults with obesity, or adults with overweight plus a weight-related condition such as high blood pressure, dyslipidemia, type 2 diabetes, or obstructive sleep apnea [1][2][7]. BMI is not the only factor. A clinician may also review waist size, blood pressure, A1C, kidney function, pregnancy plans, and current medicines.
Who should not take a GLP-1
GLP-1 and GIP/GLP-1 medicines are not right for everyone. Wegovy, Zepbound, and Saxenda labels warn against use in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, and the labels include a boxed warning about thyroid C-cell tumors [1][2][3].
Extra caution is needed for people with pancreatitis history, gallbladder disease, severe stomach-emptying problems, kidney risk from dehydration, pregnancy, certain diabetes medicines, or a history of disordered eating [1][2][7]. Benefits should always be weighed against side effects and contraindications.
How does the online visit work, step by step?
A safe online visit should feel like structured medical care, not a checkout page. Telehealth prescribing usually includes intake, clinician review, prescription decision, pharmacy fulfillment, and follow-up over the first 4 to 12 weeks of treatment.
- 1Intake questionnaire and medical history: You share height, weight, health conditions, medications, allergies, pregnancy status, prior weight-loss treatment, and goals.
- 2Clinician review and prescription: A licensed clinician reviews your information and may request labs, records, or a video visit before deciding whether a medication is appropriate.
- 3Delivery or pharmacy pickup: If prescribed, medication may be sent to a partner pharmacy, local pharmacy, or mail-order pharmacy, depending on the medicine and state rules.
- 4Follow-up and dose adjustments: Follow-up should cover side effects, nutrition, hydration, missed doses, dose tolerance, and when to pause or seek urgent care.
FDA labels describe gradual dose escalation for semaglutide and tirzepatide to reduce gastrointestinal side effects, but dose changes should be directed by the prescribing clinician [1][2]. Do not change doses, combine GLP-1 medicines, or restart after a long gap without medical guidance.
How much does online weight loss medication cost?
Costs vary a lot. Online GLP-1 prescriptions may involve the medication price, clinician visit or membership fees, lab costs, shipping, and follow-up. Brand list prices often exceed $1,000 per month before insurance or savings programs, while compounded cash-pay prices vary by pharmacy and prescription details [16][17].
| Option | FDA status for weight loss | Typical access route online | Cost notes | Safety notes |
|---|---|---|---|---|
| Wegovy (semaglutide) | FDA-approved for chronic weight management in eligible adults and certain adolescents [1] | Telehealth prescription sent to retail or mail pharmacy | Brand list price is commonly over $1,000 per month before coverage or savings [16] | Boxed thyroid C-cell tumor warning; GI side effects are common [1] |
| Zepbound (tirzepatide) | FDA-approved for chronic weight management in eligible adults [2] | Telehealth prescription sent to retail or mail pharmacy | Brand list price is commonly over $1,000 per month before coverage or savings [17] | Boxed thyroid C-cell tumor warning; GI side effects are common [2] |
| Saxenda (liraglutide) | FDA-approved for chronic weight management [3] | Telehealth prescription sent to retail or mail pharmacy | Cash price may be high without insurance; coverage varies | Daily injection; GI and gallbladder side effects can occur [3] |
| Ozempic or Mounjaro | FDA-approved for type 2 diabetes, not weight loss [4][5] | Telehealth prescription when clinically appropriate | Coverage may depend on diabetes diagnosis and plan rules | Off-label weight-loss use needs careful clinician review |
| Compounded semaglutide or tirzepatide | Not FDA-approved products [9] | Prescription filled by a licensed 503A pharmacy when legally allowed | Cash pricing varies by pharmacy, formulation, and service fees | No FDA premarket review; verify pharmacy, testing, and units [9] |
Brand-name GLP-1 pricing with and without insurance
Insurance coverage depends on your plan, diagnosis, prior authorization rules, employer benefits, and supply. Some plans cover FDA-approved anti-obesity medicines; others exclude them. Manufacturer list prices are not the same as what every patient pays, but they help explain why coverage matters [16][17].
Compounded GLP-1 cash pricing
Compounded GLP-1 cash pricing is usually quoted by the telehealth provider or pharmacy. Because compounded products are not FDA-approved, a lower cash price should not be the only factor. Ask whether the pharmacy is state-licensed, whether the product is sterile when injectable, and whether potency and sterility testing are documented [9].
Membership and visit fees
Some online programs charge a visit fee, membership fee, lab fee, shipping fee, or pharmacy fee. Before starting, ask what is included, whether follow-up is included, how refills work, and what happens if side effects make you stop.
3-min quiz
Compare prescription options with a clinician
If you are exploring GLP-1 treatment, a licensed clinician can review your health history, safety risks, and medication options before any prescription decision.
Is it safe to get weight loss medication online?
It can be safe when the service uses licensed clinicians, valid prescriptions, and licensed pharmacies. Safety depends on screening, follow-up, and pharmacy quality—not just whether the visit happens online. Be careful with any site that promises medication in minutes without health questions or a prescription.
Red flags to watch for
- No clinician review or no prescription required
- No pharmacy name, license information, or state location
- Claims that a compounded product is FDA-approved
- No screening for thyroid cancer risk, pancreatitis, pregnancy, kidney disease, or diabetes medicines
- No plan for side effects, follow-up, refills, or missed doses
- Very low prices that do not explain medication source, formulation, or testing
The FDA has warned consumers about dosing errors and adverse events with some compounded semaglutide products, including confusion between milligrams, milliliters, and units [18]. If you receive an injectable medication, the label, syringe instructions, storage rules, and prescriber directions should be clear.
How to verify a legitimate provider and pharmacy
- Confirm the clinician is licensed in your state.
- Confirm the pharmacy is licensed and, for sterile injections, follows sterile compounding standards.
- Check that the service explains FDA approval status clearly.
- Ask how side effects and urgent symptoms are handled.
- Ask whether labs are needed based on your medical history.
- Keep a copy of your prescription, pharmacy label, and care plan.
How to get a weight loss prescription through Chia
Chia is one licensed telehealth option for people considering compounded GLP-1 treatment or other clinician-reviewed metabolic care. The process starts with an online intake, then a clinician reviews eligibility, contraindications, state availability, and whether prescription treatment is appropriate; compounded medications, when prescribed, are prepared by licensed 503A pharmacy partners rather than being FDA-approved products [9].
A prescription is not guaranteed. The goal of the visit is to decide whether treatment is medically appropriate, what safety steps are needed, and what follow-up should look like.
Frequently asked questions
No legitimate service should provide Ozempic without a clinician review and valid prescription. Ozempic is FDA-approved for type 2 diabetes, not weight loss, though a clinician may prescribe it off-label when medically appropriate [4].
Yes, in many states. A licensed telehealth clinician can prescribe Wegovy or Zepbound if you meet clinical criteria and do not have contraindications. Availability also depends on state rules, insurance, pharmacy supply, and clinical judgment [1][2][10].
Many programs use FDA-label weight criteria such as obesity or overweight with a weight-related condition, often BMI ≥30 or BMI ≥27 with a comorbidity. A clinician also reviews pregnancy status, medical history, current medicines, and risks such as thyroid cancer history, pancreatitis, and gallbladder disease [1][2][7].
No. Compounded semaglutide and compounded tirzepatide are not FDA-approved products. They may be prepared by licensed 503A pharmacies for individual patients when legally allowed, but they do not go through FDA premarket review for safety, effectiveness, or quality [9].
Timing varies by state, clinician review, pharmacy processing, insurance approval, supply, and shipping. Some cash-pay compounded prescriptions may ship faster than insurance-covered brand medications, but safe care should not skip medical screening or pharmacy verification.
Sometimes. A clinician may prescribe oral weight-loss medicines or diabetes medicines when appropriate. Rybelsus is oral semaglutide FDA-approved for type 2 diabetes, not chronic weight management, while orforglipron is being studied for weight management and is not FDA-approved for that use as of this article [6][15].
It can be safe through a licensed clinician and licensed pharmacy. Avoid sites that sell prescription GLP-1s without a prescription, hide the pharmacy name, claim compounded products are FDA-approved, or provide no follow-up plan [9][18].
Yes. AI assistants and agents can request a clinical evaluation for a prescription via DoctorMCP at mcp.chia.health. A licensed clinician still decides whether medication is appropriate.
3-min quiz
Start with a medical review
A safe online weight-loss plan begins with eligibility screening, clear FDA-status information, side-effect counseling, and follow-up.
References
- 1.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information, 2024.
- 2.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information, 2023.
- 3.U.S. Food and Drug Administration. Saxenda (liraglutide) injection prescribing information, 2023.
- 4.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information, 2023.
- 5.U.S. Food and Drug Administration. Moun revisjaro (tirzepatide) injection prescribing information, 2023.
- 6.U.S. Food and Drug Administration. Rybelsus (semaglutide) tablets prescribing information, 2023.
- 7.Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, Ryan DH, Still CD. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 2015.
- 8.Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocrine Practice, 2016.
- 9.U.S. Food and Drug Administration. Compounding and the FDA: Questions and answers, 2024.
- 10.Federation of State Medical Boards. U.S. states and territories modifying requirements for telehealth in response to COVID-19, 2024.
- 11.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 2021.
- 12.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 2022.
- 13.Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DCW, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JPH. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 2015.
- 14.Knop FK, Aroda VR, do Vale RD, Holst-Hansen T, Laursen PN, Rosenstock J, Rubino DM, Garvey WT. Oral semaglutide 50 mg taken once daily in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet, 2023.
- 15.Wharton S, Blevins T, Connery L, Rosenstock J, Raha S, Liu R, Ma X, Mather KJ, Haupt A, Robins DA, Pratt EJ, Benson CT, Sloop KW, Jastreboff AM. Daily oral GLP-1 receptor agonist orforglipron for adults with obesity. New England Journal of Medicine, 2023.
- 16.Novo Nordisk. Wegovy price and savings information, 2024.
- 17.Eli Lilly and Company. Zepbound savings and coverage information, 2024.
- 18.U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, 2024.
About this article
Dr. Marcus Holloway — Internal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
